A Study to Evaluate Enfortumab Vedotin in Subjects With Locally Advanced or Metastatic Malignant Solid Tumors (EV-202)
Astellas Pharma Inc
Astellas Pharma Inc
GlaxoSmithKline
Seagen Inc.
Seagen Inc.
Incyte Corporation
Hoffmann-La Roche
Daiichi Sankyo
Aveta Biomics, Inc.
I-Mab Biopharma US Limited
Pfizer
Tempus AI
BeiGene
PDS Biotechnology Corp.
BioAtla, Inc.
QBiotics Group Limited
ALX Oncology Inc.
ALX Oncology Inc.
Ascendis Pharma A/S
Regeneron Pharmaceuticals
Elevation Oncology
HitGen Inc.
EpicentRx, Inc.
EpicentRx, Inc.
Rakuten Medical, Inc.
Novartis
Merck Sharp & Dohme LLC
Rakuten Medical, Inc.
Kura Oncology, Inc.
Kura Oncology, Inc.
Catalysis SL
Brooklyn ImmunoTherapeutics, LLC
MacroGenics
Pfizer
Tosk, Inc.
Tosk, Inc.
Hoffmann-La Roche
Genmab
Endocyte
SynCore Biotechnology Co., Ltd.
Bristol-Myers Squibb
Amgen
Galera Therapeutics, Inc.
Bristol-Myers Squibb
Bayer
PCI Biotech AS
Chinook Therapeutics, Inc.
Santalis Pharmaceuticals, Inc.
Adaptimmune
Otsuka Pharmaceutical Co., Ltd.
BioMimetix JV, LLC